Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)
Clinical trial NCT00620867 · COMPLETED
Trial details
- NCT number
- NCT00620867
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Primary completion
- 2003-03-01
- Enrollment
- 393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.